Clicky

Episurf Medical AB (publ)(EPIS-B)

Description: Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in the Nordic countries, Germany, the United Kingdom, and internationally. It offers Episealer Condyle Solo for the treatment of localized cartilage and underlying bone defects on the femoral condyles of the knee joint; Episealer Trochlea Solo to treat localized cartilage and underlying bone defects in the area behind the patella; and Episealer Femoral Twin for the treatment of elongated localized cartilage and underlying bone defects on the femoral condyles and in the trochlea area of the knee joint. The company also provides Episealer Talus for osteochondral lesions of the talar dome of the ankle joint; Epiguide, a surgical drill guide; and Epiguide MOS, a surgical drill guide, which is designed for use in mosaicplasty surgery for treatment of cartilage and deep underlying bone defects in the knee joint. In addition, it offers µiFidelity, an order management system, for placing and following up on order, uploading MRI scans, and consult patient's damage marking report. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is headquartered in Stockholm, Sweden.


Keywords: Surgery MRI Knee Skeletal System Cartilage Musculoskeletal System Osteochondritis Dissecans Autologous Chondrocyte Implantation

Home Page: episurf.com

KarlavAegen 60
Stockholm, 114 49
Sweden
Phone: 46 86 12 00 20


Officers

Name Title
Mr. Pal Ryfors Chief Exec. Officer
Mr. Patrick Jamnik Pres
Ms. Veronica Wallin Chief Financial Officer
Ms. Katarina Flodström Ph.D. Chief Operating Officer
Mr. Fredrik Zetterberg Marketing Director
Mr. Michael Näsström Head of Quality & Regulatory Affairs
Mr. Stephen Caswell Head of Sales of OUS
Beata Lihammar Principal Auditor

Exchange: ST

Country: SE

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 2.3084
Price-to-Sales TTM: 74.3905
IPO Date:
Fiscal Year End: December
Full Time Employees: 31
Back to stocks